Kiniksa Pharmaceuticals International, plc Effective Income Tax Rate Reconciliation, Tax Contingency, Amount
Kiniksa Pharmaceuticals International, plc (KNSA) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Amount of $10.95 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxContingencies · last filed 2026-02-24
- Kiniksa Pharmaceuticals International, plc effective income tax rate reconciliation, tax contingency, amount for fiscal 2025 was $10.95M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount 12 month |
|---|---|
| 2025-12-31 | $10.95M 10-K · filed 2026-02-24 |